Overview

Comparison of Efficacy of Double Dose Oral Terbinafine Vs Itraconazole in Treatment of Dermatophyte Infections of Skin.

Status:
Recruiting

Trial end date:
2022-03-31

Target enrollment:
0

Participant gender:
All

Summary

Study would be conducted to compare the efficacy and safety of double than usual dose oral terbinafine versus itraconazole in treatment of dermatophyte infections of skin in patient presenting at dermatology department of Pak Emirates Military Hospital, Rawalpindi, Pakistan.

Phase:

Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Pak Emirates Military Hospital

Treatments:

Itraconazole
Terbinafine

Criteria

Inclusion Criteria:

- individuals with dermatophyte skin infection, aged 15-50 years with one or no
co-morbidities.

Exclusion Criteria:

- individuals with two or more co-morbidities or known cases of chronic liver disease.